NCT02027376 2023-04-03EDALINESpanish Breast Cancer Research GroupPhase 1 Completed12 enrolled 16 charts
NCT01576666 2020-12-19Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsNovartisPhase 1 Completed120 enrolled
NCT01757327 2015-04-27LDE225 in Treating Patients With Stage II-III Estrogen Receptor- and HER2-Negative Breast CancerWashington University School of MedicinePhase 2 Withdrawn